Literature DB >> 16405542

Hospitalization, surgery, and readmission rates of IBD in Canada: a population-based study.

Charles N Bernstein1, Alice Nabalamba.   

Abstract

BACKGROUND: We aimed to define the rates of hospitalization and readmission for inflammatory bowel disease in Canada.
METHODS: The data source was Statistics Canada Person Oriented Information Database (1994-2001). The number of stays for a diagnosis of Crohn's disease (CD) or ulcerative colitis (UC) by ICD-9-CM code 555 or 556 was extracted (and assessed when CD or UC was the first diagnosis or was 1 of 16 diagnoses on the patient discharge abstract). Age-, gender-, and disease-specific rates of hospitalization, length of stay, readmission, and surgery were assessed.
RESULTS: The age-adjusted hospitalization rate for CD declined over 1994-2001 from 29.2 to 26.9/100,000 but was stable for UC at 12.6-13.3 per 100,000. In the 7 yr, 39.4% of CD patients (21.3-24.0%/yr) and 33.7% of UC patients (18.5-20.3%/yr) got readmitted at least once. The average length of stay declined from 10.3 (1994-1995) to 9.1 days (2000-2001) (p = 0.029) in CD and in UC declined from 12.2 to 10.1 days (p = 0.054). Of all hospitalizations, major surgery occurred in 48% of CD (44.8-49.8% per yr) and 55% of UC (51.5-59.0% per yr).
CONCLUSIONS: Rates of hospitalization declined slightly for CD over the 7 yr but still remained twice as great as the rates for UC. Approximately 20% of CD and UC subjects got readmitted per year and over 7 yr approximately 35% got readmitted. Major surgery was a more common reason for hospitalization in UC than in CD.

Entities:  

Mesh:

Year:  2006        PMID: 16405542     DOI: 10.1111/j.1572-0241.2006.00330.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  42 in total

1.  Day-by-Day Management of the Inpatient With Moderate to Severe Inflammatory Bowel Disease.

Authors:  Sara Lewin; Fernando S Velayos
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-09

2.  Analysis of Hospital-Based Emergency Department Visits for Inflammatory Bowel Disease in the USA.

Authors:  Mahesh Gajendran; Chandraprakash Umapathy; Priyadarshini Loganathan; Jana G Hashash; Ioannis E Koutroubakis; David G Binion
Journal:  Dig Dis Sci       Date:  2015-09-30       Impact factor: 3.199

3.  Through the endoscope balloon dilation of ileocolonic strictures: prognostic factors, complications, and effectiveness.

Authors:  Jörg C Hoffmann; Frank Heller; Siegbert Faiss; Bernd von Lampe; Anton J Kroesen; Ulrich Wahnschaffe; Jörg-Dieter Schulzke; Martin Zeitz; Christian Bojarski
Journal:  Int J Colorectal Dis       Date:  2008-03-13       Impact factor: 2.571

Review 4.  Quality of care delivered to hospitalized inflammatory bowel disease patients.

Authors:  Adam V Weizman; Geoffrey C Nguyen
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

Review 5.  Surgery for Crohn's disease in the era of biologicals: a reduced need or delayed verdict?

Authors:  Anthony de Buck van Overstraeten; Albert Wolthuis; André D'Hoore
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

Review 6.  The pharmacoeconomics of biologic therapy for IBD.

Authors:  Russell D Cohen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-02       Impact factor: 46.802

7.  Modifiable Risk Factors for Hospital Readmission Among Patients with Inflammatory Bowel Disease in a Nationwide Database.

Authors:  Edward L Barnes; Bharati Kochar; Millie D Long; Michael D Kappelman; Christopher F Martin; Joshua R Korzenik; Seth D Crockett
Journal:  Inflamm Bowel Dis       Date:  2017-06       Impact factor: 5.325

8.  Assessing the educational needs of Canadian gastroenterologists and gastroenterology nurses: challenges to optimal care in Crohn's Disease.

Authors:  Martin Dupuis; John K Marshall; Sean M Hayes; Kayla Cytryn; Suzanne Murray
Journal:  Can J Gastroenterol       Date:  2009-12       Impact factor: 3.522

9.  Long-term direct costs before and after proctocolectomy for ulcerative colitis: a population-based study in Olmsted County, Minnesota.

Authors:  Stefan D Holubar; Kirsten Hall Long; Edward V Loftus; Bruce G Wolff; John H Pemberton; Robert R Cima
Journal:  Dis Colon Rectum       Date:  2009-11       Impact factor: 4.585

10.  Oh my aching gut: irritable bowel syndrome, Blastocystis, and asymptomatic infection.

Authors:  Kenneth F Boorom; Huw Smith; Laila Nimri; Eric Viscogliosi; Gregory Spanakos; Unaiza Parkar; Lan-Hua Li; Xiao-Nong Zhou; Ulgen Z Ok; Saovanee Leelayoova; Morris S Jones
Journal:  Parasit Vectors       Date:  2008-10-21       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.